Global Neurostimulation Market Opportunities & Forecast (2018-2025)-GMI Research

1. Global Neurostimulation Market Opportunities & Forecast (2018-2025)-GMI Research Posted by Sarah Nash December 19, 2018 in Healthcare Global Neurostimulation Market by Product Type (Implantable {Deep Brain Stimulators, Sacral Nerve Stimulator, Spinal Cord Stimulators, Vagus Nerve Stimulators and Others} and Non-implantable {Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS)}), By Indication (Chronic pain, Movement disorders, Epilepsy and others), By End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and by Geography – Opportunities & Forecast, 2018-2025

2. The global neurostimulation market was valued at USD 5,716.5 million in 2017, and is projected to reach USD 14,476.4 million by the end of 2025, growing at a CAGR of 12.6% during 2018–2025. Figure 1: Global Neurostimulation Market Revenue, 2018–2025 (USD Million) Source: GMI Research Request Sample Pages : https://tinyurl.com/ya87rn7f The key factors bolstering the market growth are increasing prevalence of neurological disorders, such as epilepsy, Parkinson’s disease, dystonia, depression, migraine, and chronic pain. In addition, strong clinical needs, expanding research activities and advances in neural stimulation technology in combination with a deeper understanding of the nervous system are also expected to aid the market growth. Based on product type, implantable spinal cord stimulators segment is anticipated to lead the market during 2018–2025 Implantable spinal cord stimulators product type segment is expected to dominate the market during the forecast period due to an increase in clinical trials for the treatment of new indications. Moreover, the adoption of spinal cord stimulators is high as compared to conventional treatments as spinal cord

3. stimulation procedure is minimally invasive, provides quicker recovery and is cost-effective. The chronic pain by indication segment held the largest share in 2017 in the market, and is predicted to exhibit a significant growth rate during the forecast period owing to rising patients’ emphasis on timely and effective pain management and increase in prevalence of chronic pain disorder, globally. For instance, according to the American Academy of Pain Medicine, in 2011, more than 100.0 million people were affected by the chronic pain in the United States. Also, extensive research and development activities and the introduction of advanced neurostimulation products are predicted to aid the market growth in the coming years. Players, such as Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., and Nevro Corp are focusing on R&D activities to expand their product portfolio. Figure 2: Global Neurostimulation Market Revenue, by Region, 2017 Source: GMI Research Based on geography, North America held the largest share in the market in 2017 due to the presence of well-developed healthcare infrastructure, growing awareness among individuals about neurostimulation, and increasing adoption of

4. neurostimulation procedures in the region. Asia-Pacific is the fastest growing region in global neurostimulation market and is projected to grow at CAGR of 14.2% during 2018-2025 due to the presence of a large patient pool, rising disposable income, etc. Various notable players operating in the market include Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., Nevro Corp, NeuroPace, Inc., DePuy Synthes, NeuroSigma, Inc., Synapse Biomedical Inc., MED-EL., among others. The global neurostimulation market has been segmented on the basis of product type, indication, end user, and key geographies. Based on the product type, global neurostimulation market has been segmented into implantable and non- implantable. Wherein, the implantable segment includes deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators, and others and non-implantable segment includes transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Based on indication type, global neurostimulation market has been segmented into chronic pain, movement disorders, epilepsy, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and specialty clinics. The research report “global neurostimulation market” provides in-depth analysis of neurostimulation market, globally, based on product type, indication, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fueling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for neurostimulation market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

5. Key questions answered in this research report: 1- At what pace is neurostimulation market growing, globally? What will be the growth trend in future? 2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years? 3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the neurostimulation market? 4- What are the various application areas and how they are poised to grow? For Sample Pages & Detailed Report Description Click @ https://www.gmiresearch.com/report/global-neurostimulation-market- product-type-indication-end-user-opportunities-forecast-share-trends-industry- analysis.html Table of Contents (TOC) 1. Executive Summary 2. Introduction 2.1. Study Objectives 2.2. Market Definition 2.2.1. Market Covered 2.2.2. Geographical Coverage 2.2.3. Study Years & Currency 2.3. Market Stakeholders 2.4. Key Questions this Study will Answer 2.5. GMI Research’s Approach & Methodology

6. 3. Global Neurostimulation Market – Overview 3.1. Introduction ` 3.2. Market Segmentation 3.3. Value Chain Analysis 3.4. Drivers 3.5. Restraints 3.6. Trends 4. Global Neurostimulation Market Revenue Forecast till 2025 5. Global Neurostimulation Market by Product Type Revenue Forecast till 2025 5.1. Implantable 5.1.1. Deep Brain Stimulators 5.1.2. Sacral Nerve Stimulator 5.1.3. Spinal Cord Stimulators 5.1.4. Vagus Nerve Stimulators 5.1.5. Others 5.2. Non-implantable 5.2.1. Transcranial Magnetic Stimulation (TMS) 5.2.2. Transcutaneous Electrical Nerve stimulation (TENS) 6. Global Neurostimulation Market by Indication Revenue Forecast till 2025 6.1. Chronic pain 6.2. Movement disorders 6.3. Epilepsy 6.4. Others 7. Global Neurostimulation Market by End User Revenue Forecast till 2025 7.1. Hospitals

7. 7.2. Ambulatory Surgical Centers 7.3. Specialty Clinics 8. Global Neurostimulation Market by Geography Revenue Forecast till 2025 8.1. North America Neurostimulation Market Revenue Forecast till 2025 8.1.1. North America Neurostimulation Market by Product Type (Option 1: 25% customization) 8.1.1.1. Implantable 8.1.1.1.1. Deep Brain Stimulators 8.1.1.1.2. Sacral Nerve Stimulator 8.1.1.1.3. Spinal Cord Stimulators 8.1.1.1.4. Vagus Nerve Stimulators 8.1.1.1.5. Others 8.1.1.2. Non-implantable 8.1.1.2.1. Transcranial Magnetic Stimulation (TMS) 8.1.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS) 8.1.2. North America Neurostimulation Market by Indication 8.1.2.1. Chronic pain 8.1.2.2. Movement disorders 8.1.2.3. Epilepsy 8.1.2.4. Others 8.1.3. North America Neurostimulation Market by End User 8.1.3.1. Hospitals 8.1.3.2. Ambulatory Surgical Centers 8.1.3.3. Specialty Clinics 8.2. Europe Neurostimulation Market Revenue Forecast till 2025 8.2.1. Europe Neurostimulation Market by Product Type (Option 2: 25% customization)

8. 8.2.1.1. Implantable 8.2.1.1.1. Deep Brain Stimulators 8.2.1.1.2. Sacral Nerve Stimulator 8.2.1.1.3. Spinal Cord Stimulators 8.2.1.1.4. Vagus Nerve Stimulators 8.2.1.1.5. Others 8.2.1.2. Non-implantable 8.2.1.2.1. Transcranial Magnetic Stimulation (TMS) 8.2.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS) 8.2.2. Europe Neurostimulation Market by Indication 8.2.2.1. Chronic pain 8.2.2.2. Movement disorders 8.2.2.3. Epilepsy 8.2.2.4. Others 8.2.3. Europe Neurostimulation Market by End User 8.2.3.1. Hospitals 8.2.3.2. Ambulatory Surgical Centers 8.2.3.3. Specialty Clinics 8.3. Asia-Pacific Neurostimulation Market Revenue Forecast till 2025 8.3.1. Asia-Pacific Neurostimulation Market by Product Type (Option 3: 25% customization) 8.3.1.1. Implantable 8.3.1.1.1. Deep Brain Stimulators 8.3.1.1.2. Sacral Nerve Stimulator 8.3.1.1.3. Spinal Cord Stimulators 8.3.1.1.4. Vagus Nerve Stimulators 8.3.1.1.5. Others

9. 8.3.1.2. Non-implantable 8.3.1.2.1. Transcranial Magnetic Stimulation (TMS) 8.3.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS) 8.3.2. Asia-Pacific Neurostimulation Market by Indication 8.3.2.1. Chronic pain 8.3.2.2. Movement disorders 8.3.2.3. Epilepsy 8.3.2.4. Others 8.3.3. Asia-Pacific Neurostimulation Market by End User 8.3.3.1. Hospitals 8.3.3.2. Ambulatory Surgical Centers 8.3.3.3. Specialty Clinics 8.4. Rest of the World Neurostimulation Market Revenue Forecast till 2025 8.4.1. Rest of the World Neurostimulation Market by Product Type (Option 4: 25% customization) 8.4.1.1. Implantable 8.4.1.1.1. Deep Brain Stimulators 8.4.1.1.2. Sacral Nerve Stimulator 8.4.1.1.3. Spinal Cord Stimulators 8.4.1.1.4. Vagus Nerve Stimulators 8.4.1.1.5. Others 8.4.1.2. Non-implantable 8.4.1.2.1. Transcranial Magnetic Stimulation (TMS) 8.4.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS) 8.4.2. Rest of the World Neurostimulation Market by Indication 8.4.2.1. Chronic pain 8.4.2.2. Movement disorders

10. 8.4.2.3. Epilepsy 8.4.2.4. Others 8.4.3. Rest of the World Neurostimulation Market by End User 8.4.3.1. Hospitals 8.4.3.2. Ambulatory Surgical Centers 8.4.3.3. Specialty Clinics 9. Competitive Landscape 9.1. Porter 5 Analysis 9.2. Major players and their key strategies 9.3. Company Share Analysis 10. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice) 10.1. Medtronic plc 10.1.1. Company Overview 10.1.2. Financials 10.1.3. Recent Developments 10.2. Cyberonics Inc. 10.2.1. Company Overview 10.2.2. Financials 10.2.3. Recent Developments 10.3. NeuroPace, Inc. 10.3.1. Company Overview 10.3.2. Financials 10.3.3. Recent Developments 10.4. NeuroSigma, Inc. 10.4.1. Company Overview 10.4.2. Financials 10.4.3. Recent Developments

11. 10.5. Nevro Corp. 10.5.1. Company Overview 10.5.2. Financials 10.5.3. Recent Developments 10.6. Depuy Synthes 10.6.1. Company Overview 10.6.2. Financials 10.6.3. Recent Developments 10.7. Synapse Biomedical Inc. 10.7.1. Company Overview 10.7.2. Financials 10.7.3. Recent Developments 10.8. Boston Scientific Corporation 10.8.1. Company Overview 10.8.2. Financials 10.8.3. Recent Developments 10.9. Bayer Corporation 10.9.1. Company Overview 10.9.2. Financials 10.9.3. Recent Developments 10.10. BioControl Medical 10.10.1. Company Overview 10.10.2. Financials 10.10.3. Recent Developments 11. About GMI Research Buy Report @ https://tinyurl.com/ya87rn7f Related Report :

12. Global Behavioral Health Market by Services Type (Inpatient Hospital Treatment, Outpatient Counselling, Home-Based Treatment Services, Emergency Mental Health Services, and Intensive Care Management), By Disorder (Anxiety Disorder, Bipolar Disorder, Depression, Eating Disorder, Post-Traumatic Stress Disorder, Substance Abuse Disorder and Others) End-Users (Outpatient Clinics, Rehabilitation Centers, Hospitals (Emergency), Homecare Setting) and by Geography – Opportunities & Forecast, 2018-2025 About US GMI Research is a market research and consulting firm which provides research- based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and

13. experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligenc e.html Our Company Profile Solution Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients. We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html Contact – Sarah Nash Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate, Dublin D18 Y3X2, Ireland U.S Office +1 860 881 2270 Europe Office +353 1 442 8820 Email: sales@gmiresearch.com